chlorphenesin (maolate) Report issue

Small molecule Approved FDA
ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Chlorphenesin carbamate (Maolate, Musil) is a centrally acting muscle relaxant used to treat muscle pain and spasms. Сhlorphenesin acts in the central nervous system (CNS) rather than directly on skeletal muscle. It also has antifungal and some antibacterial properties. The major adverse effects are drowsiness and dizziness.   NCATS

Chemistry

  • SMILES: NC(=O)OCC(O)COC1=CC=C(Cl)C=C1
  • InChIKey: SKPLBLUECSEIFO-UHFFFAOYSA-N
  • Mol. Mass: 245.66
  • ALogP: 1.17
  • ChEMBL Molecule:
    chlorphenesin carbamate  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Oral
  • Pro Drug: No

Alternative names

3-(4-chlorophenoxy)-1,2-propanediol | 3-(p-chlorophenoxy)-1,2-propanediol | 3-(p-chlorophenoxy)propane-1,2-diol | chlorphenesin | chlorphenesin carbamate | chlorphénésine | chlorphenesinum | chlorphensin carbamate | clorfenesina | glycerol alpha-p-chlorophenyl ether | maolate | p-chlorophenyl-alpha-glyceryl ether | u-19646

Organizations (5)

Research & Development (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (3)

Approved Indications (2)


 

Musculoskeletal Pain (approved 1965)

Spasm (approved 1965)

Experimental Indications - Clinical Trial Phases 1-4 (1)


 

Pancreatic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial Organizations: 3

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue